Relationship Between the Apolipoprotein AI, B Gene Polymorphism and the Risk of Non-traumatic Osteonecrosis
Overview
Endocrinology
Affiliations
Background: Previous studies suggested that Apolipoprotein AI (ApoAI) and apolipoprotein B (ApoB) gene polymorphisms may result in lipid metabolism disorders. Genetic polymorphisms in these genes may be associated with the occurrence of osteonecrosis.
Methods: We designed a case-control study including 429 patients of osteonecrosis and 368 age- and sex-matched control subjects. Polymerase chain reaction was used to amplify the DNA fragments in promoter -75 G > A of ApoAI gene and EcoR I, Xba I and 3'-VNTR of ApoB gene in osteonecrosis patients and healthy controls. We utilized polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method to genotype these four single nucleotide polymorphisms (SNPs).
Results: For -75 G > A polymorphism of ApoAI, AA genotype frequency (0.501) was significantly higher in patients with osteonecrosis than that in control (0.462) subjects (P <0.001), GA genotype frequency (0.170) was significantly lower than that in the control (0.310) group (P <0.0001). In osteonecrosis patients, the odds ratio (OR) of A allele was 3.932 (95% CI: 3.0847 ~ 5.0123), which suggested that subjects carrying A allele of promoter region -75 G > A of ApoAI gene had higher susceptibility to osteonecrosis than G allele carriers. The genotype and allele frequency distributions showed no significant difference in EcoR I, Xba Iand 3'-VNTR loci of ApoB gene between the osteonecrosis group and control group.
Conclusion: Our study suggested that ApoAI gene -75G > A polymorphism may be associated with susceptibility to osteonecrosis in Chinese population. However, our results need further investigation with large sample size and various populations.
Liu C, Liu X, Li X Pharmgenomics Pers Med. 2022; 15:797-808.
PMID: 36110408 PMC: 9469939. DOI: 10.2147/PGPM.S369957.
Liu T, Cao Y, Han C, An F, Wang T, Sun M J Orthop Surg Res. 2021; 16(1):673.
PMID: 34781979 PMC: 8594148. DOI: 10.1186/s13018-021-02669-y.
Li Q, Chen R, Yu Y, Wang X, Feng X, Jiang L Medicine (Baltimore). 2020; 99(40):e22598.
PMID: 33019480 PMC: 7535671. DOI: 10.1097/MD.0000000000022598.
Han J, Gao F, Li Y, Ma J, Sun W, Shi L Biomed Res Int. 2020; 2020:2642439.
PMID: 32219128 PMC: 7081027. DOI: 10.1155/2020/2642439.
An F, Du J, Wang J, Zhao L, Ma C, Zhao J Med Sci Monit. 2019; 25:3750-3761.
PMID: 31106781 PMC: 6540618. DOI: 10.12659/MSM.913918.